Craig Schulz is the Chief Platform Officer at Terray Therapeutics since April 2021. Prior to this, Craig worked at Amgen from November 2002 to April 2021 as a Principal Scientist. Craig holds a PhD in Chemistry from the University of Washington and a BA in Chemistry from St. Olaf College.